Dr. Khasraw was recently featured in an audio interview to provide insight into the current state of cancer immunotherapy, highlighting how rapidly evolving approaches—such as personalized immune‑based treatments, improved biomarker‑guided patient selection, and next‑generation cellular therapies—are reshaping clinical practice and research priorities. He emphasizes the growing integration of immunotherapy across cancer types, the challenges of resistance and toxicity, and the importance of multidisciplinary collaboration to translate scientific breakthroughs into better patient outcomes. Lastly, in contextualizing emerging discoveries, he discusses their broader implications for future clinical care and research.
Listen to the full interview here.